Eir Ventures

Eir Ventures is a specialist life sciences venture capital firm founded in 2020 and based in Stockholm, Sweden. It invests across the broad spectrum of biotechnology and life sciences companies, financing the development of innovative medicine and supporting the translation of medical research into therapies, with a particular focus on the Nordic region.

Since launch the firm has invested in 17 life science companies, backing high-potential opportunities intended to advance development programmes toward new therapies. Five portfolio companies have seen their development programmes advance further since investment, indicating a portfolio pattern weighted towards drug and therapy development rather than platform services or diagnostics alone. The firm describes itself as a specialist, high-conviction investor in high-potential life science opportunities.

Its stated approach is to use a strong Nordic base and focus to leverage global medical research, with an emphasis on the potential benefits to patients. The technical domains covered include biotechnology, life sciences, medical research, drug and therapy development, and innovative medicine; the wider sector verticals span biotechnology, pharmaceuticals, healthcare, and medical research. Firm size, fund structure and individual investment sizes are not disclosed.